📰 Relief Reports News
Relief Reports News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Relief Reports. Real-time updates on events, politics, business and more.
April 22, 2022
Investegate announcements from Relief Therapeutics Holding SA, Relief Reports that its U.S. Collaboration Partner has Filed a New Breakthrough Therapy Designation Request for Aviptadil
April 22, 2022
FinancialContent fully hosted finance channel
April 22, 2022
FinancialContent fully hosted finance channel
February 16, 2022
16.02.2022 - EQS-Ad-hoc: Relief Therapeutics Holding SA / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced that the U.S. National Institutes of Health Study of Aviptadil in Critical COVID-19 is Cleared to Complete Full ... Seite 1
January 27, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Research Update Relief Reports that its U.S. Collaboration Partner has Announced Receipt of Initial Report of Patient Safety and Survival from
January 19, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Miscellaneous Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients
January 6, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Regulatory Admission Relief Reports US Collab. Partner announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death
January 4, 2022
EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions
August 19, 2021
19.08.2021 - EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Reports that its U.S. Collaboration Partner has Announced a Positive Safety Report for ZYESAMI(TM) (aviptadil) in NIH Sponsored ACTIV-3 Study in Patients with ... Seite 1